NUTX
Income statement / Annual
Last year (2024), Nutex Health, Inc.'s total revenue was $479.95 M,
an increase of 93.80% from the previous year.
In 2024, Nutex Health, Inc.'s net income was $52.18 M.
See Nutex Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$479.95 M |
$247.65 M |
$219.29 M |
$331.53 M |
$273.42 M |
$97.06 M |
$91,373.00 |
$53,647.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$283.69 M
|
$212.87 M
|
$205.84 M
|
$152.25 M
|
$1.82 M
|
$1.66 M
|
$62,298.00
|
$564,367.00
|
$473.00
|
$662.00
|
| Gross Profit |
$196.26 M
|
$34.77 M
|
$13.45 M
|
$179.28 M
|
$271.60 M
|
$95.40 M
|
$29,075.00
|
-$510,720.00
|
-$473.00
|
-$662.00
|
| Gross Profit Ratio |
0.41
|
0.14
|
0.06
|
0.54
|
0.99
|
0.98
|
0.32
|
-9.52
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$285,880.00
|
$557,257.00
|
$768,103.00
|
$545,223.00
|
$25,645.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$41.92 B
|
$33.23 M
|
$18.03 M
|
$5.46 M
|
$115.13 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
-$41.87 B
|
$2.84 M
|
$0.00
|
$24,449.00
|
$166,759.00
|
$577,739.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$58.56 M
|
$36.07 M
|
$18.03 M
|
$5.46 M
|
$115.13 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$448,122.00
|
$532,326.00
|
| Other Expenses |
$0.00
|
$0.00
|
-$559,299.00
|
$5.42 M
|
$5.96 M
|
$2.48 M
|
$633,572.00
|
$3.87 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$65.64 M
|
$66.55 M
|
$18.03 M
|
$5.46 M
|
$121.09 M
|
$62.35 M
|
$1.80 M
|
$5.69 M
|
$448,122.00
|
$532,326.00
|
| Cost And Expenses |
$349.33 M
|
$279.42 M
|
$223.87 M
|
$157.71 M
|
$121.09 M
|
$62.35 M
|
$1.86 M
|
$5.69 M
|
$448,595.00
|
$532,988.00
|
| Interest Income |
$0.00
|
$0.00
|
$12.49 M
|
$917.00
|
$1,030.00
|
$3,626.00
|
$0.00
|
$0.00
|
$114.00
|
$4.00
|
| Interest Expense |
$19.93 M
|
$16.32 M
|
$12.49 M
|
$6.20 M
|
$6.43 M
|
$3.53 M
|
-$642,070.00
|
-$367,352.00
|
$2,579.00
|
$3,146.00
|
| Depreciation & Amortization |
$18.97 M
|
$17.59 M
|
$13.20 M
|
$7.76 M
|
$236,546.00
|
$179,469.00
|
$522.00
|
$535,024.00
|
$473.00
|
$662.00
|
| EBITDA |
$148.65 M |
-$14.58 M |
-$393.96 M |
$183.45 M |
-$5.12 M |
-$6.84 M |
-$839,808.00 |
-$5.11 M |
-$448,008.00 |
-$532,322.00 |
| EBITDA Ratio |
0.31
|
-0.06
|
-1.8
|
0.55
|
-0.02
|
-0.07
|
-9.19
|
-95.16
|
0
|
0
|
| Operating Income Ratio |
0.27
|
-0.13
|
-0.02
|
0.51
|
0.56
|
0.36
|
-20.03
|
-106.12
|
0
|
0
|
| Total Other Income/Expenses Net |
-$20.87 M
|
-$16.72 M
|
-$13.05 M
|
-$773,882.00
|
-$7.43 M
|
-$2.62 M
|
-$983,684.00
|
-$314,554.00
|
-$2,460.00
|
-$3,142.00
|
| Income Before Tax |
$109.75 M
|
-$48.49 M
|
-$419.65 M
|
$169.49 M
|
$145.56 M
|
$32.09 M
|
-$2.81 M
|
$582,062.00
|
-$451,060.00
|
-$536,130.00
|
| Income Before Tax Ratio |
0.23
|
-0.2
|
-1.91
|
0.51
|
0.53
|
0.33
|
-30.8
|
10.85
|
0
|
0
|
| Income Tax Expense |
$14.48 M
|
-$5.07 M
|
$13.09 M
|
$965,731.00
|
$50.83 M
|
$15.61 M
|
-$161,141.00
|
-$535,024.00
|
$6.98 M
|
-$619,941.00
|
| Net Income |
$52.18 M
|
-$45.79 M
|
-$432.74 M
|
$132.59 M
|
$105.97 M
|
$16.48 M
|
-$2.81 M
|
$582,062.00
|
-$7.43 M
|
$83,809.00
|
| Net Income Ratio |
0.11
|
-0.18
|
-1.97
|
0.4
|
0.39
|
0.17
|
-30.8
|
10.85
|
0
|
0
|
| EPS |
10.23 |
-10.39 |
-10.24 |
3.36 |
2.68 |
0.4 |
-0.0392 |
0.0139 |
-14045.09 |
1.44 |
| EPS Diluted |
10.23 |
-10.39 |
-10.22 |
3.3 |
2.68 |
0.4 |
-0.0392 |
0.0139 |
-14045.09 |
1.44 |
| Weighted Average Shares Out |
$5.10 M
|
$4.41 M
|
$42.27 M
|
$40.18 M
|
$42.92 M
|
$41.40 M
|
$71.84 M
|
$41.84 M
|
$529.17
|
$58,336.00
|
| Weighted Average Shares Out Diluted |
$5.10 M
|
$4.41 M
|
$42.33 M
|
$39.52 M
|
$42.92 M
|
$41.40 M
|
$71.84 M
|
$41.84 M
|
$529.17
|
$58,336.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
